© All rights reserved


Site Owner








In view of the rapidly developing  COVID-19 global pandemic, our focus has been redirected to this disease's pathology, potential therapeutic targets and treatment approaches. Our  publications  in this field  are shown below:

More Updates to Follow

Lessons from SARS and MERS remind us of the possible therapeutic effects of implementing a siRNA strategy to target COVID19: Shoot the messenger!

 Available online on 17  July 2020.

Should we Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy? Available online on 31 May 2020.

May we Target Double Membrane Vesicles and Oxysterol-Binding Protein to Combat SARS-CoV-2 Infection? Available online on 25 May 2020.

Neutrophil Elastase Inhibitor (Sivelestat), may be a Promising Therapeutic Option for Management of Acute Lung Injury/Acute Respiratory Distress Syndrome or Disseminated Intravascular Coagulation in COVID-19. Preprint available online on  18 May 2020.

Possible use of the mucolytic drug, bromhexine hydrochloride, as a prophylactic agent against SARS-CoV-2 infection based on its action on the Transmembrane Serine Protease 2. Pharmacological Research (IF 5.574.

4.            Available online: 30 April 2020

Should we try the anti-inflammatory natural product, celastrol, for COVID-19? Published Online: 29 April 2020.


SARS-CoV-2 infection, COVID-19 and other coronavirus diseases.. Visit our new Special Issue for article contribution.

COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.  If they have efficacy against COVID-19, this could be what we need to do improve their safety and efficacy ..

Watch Our Video Presentation

Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us to combat SARS-CoV-2. Archives of Medical Science. Published on 14 April 2020.


Repurposing Therapeutic Agents and Herbal Medicines to Defeat Viral Nemesis  - Published on 30 March 2020 - Drug Development Research

Other  Publications on Our Antiviral Activity Studies

See our  article on antiviral activity of Tansy: Álvarez, Á.L,  HABTEMARIAM, S,  Juan-Badaturuge,  M, Jackson, C, Parra, F. (2011).  In vitro anti HSV-1 and HSV-2 activity of Tanacetum vulgare extracts and isolated compounds: An approach to their mechanisms of action.  Phytotherapy Research. 25(2), 296-301.  Abstract
...See an overview of our Research on Tansy...

...See media coverage of our findings...

Álvarez, Á.L., HABTEMARIAM, S., Dalton, K.P., Nicieza, I., Parra, F. (2015. A spiroketal-enol ether derivative from Tanacetum vulgare selectively inhibits HSV-1 and HSV-2 glycoprotein accumulation in Vero cells. Antiviral Research 119, 8-18. Abstract

.... and  visit our publications' page for more references.

Bioassays on Antimicrobial Effects of Natural Products

 Available Books 


.................We value your feedback..................



The Site Owner

Dr Habtemariam BSc, MSc, PhD........FRSM, FRSC. .... With a Principal Lecturer post at Greenwich, Dr Habtemariam has been a  leader of courses and researches on bioassay & natural products-based drug development. ....More



In addition to our fully equipped tissue culture facilities, we have  access to various state-of-the-art equipment including ICP-MS, LC-MS, MALDI-TOF-MS, FABS-MS, FTIR, Laser-Raman,  scanning  and transmission  electron microscopes, flow cytometer, NMR (300, 400 and 500MHz),  automated DNA sequencers, various HPLC systems,  capillary electrophersis ................















Plant Medicine



Essential Oils

See How We Do It
Education & Training
Lectures, seminars,  workshops & short courses; undergraduate, postgraduate &  postdoctoral level education and trainings ... on pharmacology &  pharmacognosy subject areas

Modernising the old art of traditional medicines can only happen through up-to-date scientific research

Copyright © 2006 - 2020 Herbal Analysis Services